Volume 11 - Issue 3 - March 2014

Craig Walker, MD

Technology is improving that could help to reduce the incidence of contrast-induced nephropathy. | Read More

Carlos F. Bechara, MD, MS, From Baylor College of Medicine, Houston, Texas.</p>

The author examines retrospective single-center data on the spiral laminar flow graft for lower extremity bypass. | Read More

Barry S. Weinstock, MD, From the Orlando Regional Medical Center, Orlando, Florida.

The author discusses established and evolving strategies to decrease the risk of contrast nephropathy. | Read More

Jason Salsamendi, MD, Ami Vakharia, MD, Adam N. Checkver, MD, Govindarajan Narayanan, MD, and Eric Peterson, MD, From Jackson Memorial Hospital, Miami, Florida.

The authors theorize that a proximal and distal balloon occlusion technique was implemented along with a combination of coils and glue could be effective for pseudoaneurysm in various high-flow situations. | Read More

Interview by Jennifer Ford

The Valiant Mona LSA stent graft system is the first device of its kind to be studied in humans as part of the FDA’s Innovation Pathway early feasibility pilot program. | Read More